Mediaboss Marketing

President Donald Trump has maintained a steady schedule of campaign rallies, which may have exposed him to SARS-CoV-2.

By Jon CohenOct. 5, 2020 , 12:20 PM

Sciences COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.

On 2 October, the White House announced President Donald Trump received an experimental antibody treatment after a test revealed hesinfected with SARS-CoV-2. At the time, he reportedly hadmild COVID-19 symptoms, including fever and congestion, and he was transferred to Walter Reed National Military Medical Center. Later, the presidents medical team confirmed he had started a course of remdesivir, an antiviral drug shown to modestly help hospitalized COVID-19 patients. Two days later, on 4 October, the team revealed Trump had been given a steroid normally reserved for severe COVID-19 cases, although his physician offered optimism about a quick recovery, even suggesting he might soon be discharged from Walter Reed.

Its a combination of two antibodies directed against a key protein of the virus that causes COVID-19, SARS-CoV-2. They bind to a region on the main surface spike protein that helps the virus attach to a receptor on human cells calledangiotensin-converting enzyme 2. The targeted region is dubbed the receptor binding domain. One antibody comes from a human who had recovered from a SARS-CoV-2 infection; a B cell that makes the antibody was harvested from the persons blood and the genes for the immune protein isolated and copied. The other antibody is from a mouse, which was engineered to have a human immune system, that had the spike protein injected into it.

Experiments in bothgolden hamsters and rhesus macaquesthat were intentionally infected with SARS-CoV-2 showed the cocktail could reduce viral levels and disease pathology.

Regeneron, the maker of the cocktail, earlier last week presented preliminary data from its ongoing clinical trial in people who tested positive for SARS-CoV-2 but were asymptomatic or, in the most extreme cases, had moderate diseasea group that would appear to mirror Trumps current condition. No serious safety concerns surfaced, andthe treatment reduced viral loadand shortened symptomatic disease in patients who did not have SARS-CoV-2 antibodies at the trials start. Its unclear whether the treatment can prevent severe disease, but there were hints that it might: Participants who received a placebo had more medical visits.

A separate trial is assessing the impact of the treatment on hospitalized COVID-19 patients, but Regeneron has yet to report any results from that study.

Not exactly. Trump received an 8-gram infusion of the treatment. Regenerons data showed a 2.4-gram infusion worked as well as the higher dose at reducing SARS-CoV-2 levels in people. This was widely seen as good news because monoclonals are difficult and expensive to produce, and a lower dose means more people can ultimately receive it.

Likely out of an abundance of caution by the presidents medical team, says George Yancopoulos, co-founder and chief scientific officer of Regeneron. Yancopoulos does not directly know why Trumpsphysicians chose to use 8 grams, but says the companys data indicate theres very, very limited risk that the antibodies will cause harm at either dose. The higher dose might last longer, he said, and at some time points in the companys study, Regeneron did see trends suggesting the higher dose more powerfully beats back the virusthe company used the amount of viral genetic material found with nose swabs as a proxy for SARS-CoV-2 levels in the entire body.

If I had to treat one patient, Id give the high dose, Yancopoulos says. From a societal point of view and the need to treat as many people as possible, Id give the lower dose.

The Regeneron study found the treatment only worked in people who did not have SARS-CoV-2 antibodies at the start of the study. It also worked best in people who had higher levels of the virus. Whether the president had those antibodies and a high viral load has not been made public. I couldnt speculate because it has to do with an individual patient, Yancopoulos says.

No. The treatment consisted of two monoclonal antibodiesmeaning each was produced by making identical copies, or clones, of an antibody gene in a single B cell. Polyclonal antibody cocktails refer to antibodies made by mixtures of B cells.

The antibodies are typically only available to people who participate in clinical trials. Trump theoretically could have enrolled in the ongoing treatment study that reported preliminary data last week, but that trial randomly assigns half the participants to receive the antibodies; the other half serves as a control group and receives infusions of an inactive placebo. A U.S. Food and Drug Administration (FDA) regulation called expanded accesstechnically known as21 CFR 312.310allows physicians to request compassionate use of experimental treatments through an investigational new drug pathway used for individual patients or for emergencies. These are designed to be used in these rare and special circumstances, Yancopoulos says. This is not the first time weve done compassionate use for these monoclonal antibodies. This is not a mechanism for widespread distribution.

Yes. Both Regeneron and Eli Lilly, which similarly reported encouraging preliminary clinical trial data last month from a single SARS-CoV-2 monoclonal antibody, are discussing the possibility of an EUA with FDA. Lilly reported signs that its antibody reduced the need for hospitalization, but as with Regeneron, too few participants have so far become seriously ill to reach a convincing conclusion to this critical question.

Remdesivir is an antiviral drug developed by Gilead Sciences, originally to treat the hepatitis C virus. It did not perform well against that pathogen but has been tried against Ebola and other viruses, after showing some activity in cells and animal models. The drug inhibits a viral enzyme used for replication of the pathogen. Earlier this year, it demonstrateda modest clinical benefit in a trial with hospitalized COVID-19 patients, leading FDA to grant Gilead an EUA for the drug. That EUA has since been expanded for use in patients with mild disease although its benefit in them is not clear. The drug has become widely used for COVID-19 patients despitecontinuing skepticism that it has a major clinical benefit. Because it and the monoclonal antibodies target different parts of the virus, administering them together may have a synergistic effect. One COVID-19 clinical trial is testing remdesivir and Lillys antibody, for example.

On 4 October, Sean Conley, the White House physician, said in a press conference that Trump had also been started on the steroid dexamethasone. The drug dampens the bodys immune response and can keep it from wreaking havoc in the late stages of COVID-19. It is the onlytreatment so far that has been shown to reduce the mortality in patients with severe COVID-19, but there are some indications that it may actually be harmful if given too early in the disease course. In the United Kingdoms Recovery trial there was a clear benefit for patients requiring oxygen or ventilation but not for other patients. Conley said Trump had experienced two episodes of transient drops in his oxygen saturation. Independent doctors were quick to point out that dexamethasone can have serious side effects including agitation, paranoia, and even psychosis.

The statement released on 2 October by the presidents physician said that in addition to the antibodies, Trump has been taking zinc, vitamin D, famotidine, melatonin and a daily aspirin. That wording leaves unclear whether he was taking those substances before his diagnosed infection. Notably, the statement does not indicate whetherTrump was or is taking hydroxychloroquine, the antimalarial he controversially pushed as a COVID-19 treatment.

Famotidinehas been suggested to be a treatment for COVID-19, but its also a popular heartburn remedy, sold widely under the name Pepcid. A clinical trial testing it in hospitalized COVID-19 patients in New York was not able to recruit enough patients to properly evaluate its impact. The Feinstein Institutes for Medical Research, which initiated that trial, released a statement on 2 October citing evidence it was helpful for COVID-19 but also saying, We have yet to prove [famotidines] efficacy. The institute says its eagerly awaiting FDA approval of a trial that will evaluate whether famotidine can help people who are not hospitalized.

This story was originally published on 2 October at 9:25 p.m.

*Update, 3 October, 1:20 p.m.:Information about Trumps use of remdesivir was added to the story.

*Update, 5 October, 9:15 a.m.:Information about Trumps use of dexamethasone was added to the story.

View post:
Update: Here's what is known about Trump's COVID-19 treatment - Science Magazine

MINNEAPOLIS (WCCO) The Trump campaign is rolling out Operation MAGA to keep the campaign moving forward after the president tested positive for COVID-19 last week.

WCCOs Esme Murphy spoke with the presidents eldest son earlier Monday. Donald Trump Jr. says his father is doing really well, and hes not stopped working.

When I spoke to him over the weekend, thats what he was doing. He was working, he was negotiating deals. You know, I couldnt even get through initially because he was busy doing other things! Trump Jr. said.

READ MORE: White House Physicians Claim That Trump Was 72 Hours Into Diagnosis Raises Questions About Minn. Visit

He admits his fathers COVID-19 diagnosis is a major blow to the campaign.

Its less than ideal, Trump Jr. said. Hopefully people like myself can, you know, pick up at least a little bit of that slack.

He dismisses reports that claim he and other family members are concerned about the presidents mental state after his controversial drive outside Walter Reed Medical Center, and an unusually large number of tweets mostly in capital letters.

Those reports are 100% false. I saw that on Twitter myself and I laughed, he said. Thats one of those, you know, left wing folks trying to create a controversy.

Trump Jr. denies what critics are claiming: The presidents diagnosis, and that of so many around him, shows he has wrongly and even dangerously downplayed the pandemic.

I think its ridiculous. The reality is, you know, Ive seen the protocols that go through for him. Its still a virus, just like we cant stop the flu entirely. We can take precautions, but we cant shut down the whole country again, like Joe Biden would do.

READ MORE: Paul Gazelka, Jason Lewis Tests Negative For COVID-19 After Meeting With Trump Last Week

And Trump Jr. expects to see his father back on the campaign trail soon, including possible stops in Minnesota.

Its a very important state. You know, Ive been there a bunch myself, he said. Theres obviously nothing quite like a Donald Trump in-person rally, you know, to get people going.

The president is expected to be released from the hospital and return to the White House Monday at about 6:30 p.m. CST.

Read the original post:
Donald Trump Jr. Dismisses Ridiculous Claims That His Father Downplayed Pandemics Severity - CBS Minnesota

WASHINGTON President Donald Trump continues to improve in his battle against COVID-19 and could be discharged as early as Monday, a White House physiciansaid Sunday, as White Houseaides sought to paintan image of business as usual despite uncertainty over the severity of the president's condition.

Navy Commander and White House physicianSean Conleysaiddoctors gave Trump supplemental oxygenon Friday,something he previouslyrefused to discuss,after the presidenthad a "high fever" and his oxygen levels dipped below 94%. Hesaid Trump experiencedanother drop in oxygen on Saturday, but did not discuss treatment.

"There are frequent ups and downs ... particularly when a patient is being so closely watched 24 hours a day," said Conley. "Ifhe continues to look and feel as well as he does today, our hope is that we can plan for a discharge as early as tomorrow to the White House, where he can continue his treatment course."

Conley, seeking to clear up confusion from comments he madeSaturday, said Trump has "experienced two episodes of transient drops" inhis oxygen saturation, but that has been treated with medication.Conley was not specific about Trump's exact oxygen levelsand refused to say whether the president is in a negative pressure room, which hospitals sometimes use to helpprevent airborne diseases from escaping and infecting other people.

Dr. Sean Dooley, who is also treating the president, said Trump was given the steroid dexamethasone on Saturday following hisoxygen drop.The World Health Organization recommends that drug only for "severe and critical" cases. Dooley said the president will continue to receive the steriod"for the time being."

Thepresident alsocompleted his second dose of the antiviral drugremdesiviron Saturday and will continue his five-day course of remdesivir.

Asked why he evaded questions on Saturday about whether the president received supplemental oxygen, Conley said he was trying to reflect the "upbeat attitude of the president."

Dr. Sean Conley, physician to President Donald Trump, briefs reporters at Walter Reed National Military Medical Center in Bethesda, Md., Sunday, Oct. 4, 2020. Trump was admitted to the hospital after contracting the coronavirus. (AP Photo/Jacquelyn Martin)(Photo: Jacquelyn Martin, AP)

"I was trying to reflectthe upbeat attitude that the team, thepresident, his course of illness has had," Conley said, adding that he "didn't want to giveany information that might steer the course of illness in another direction."

"Andin doing so, you know, came off (like) we'retrying to hide something, whichwasn't necessarilytrue," he added.

Throughout the weekend, the White House has sent mixed messages aboutTrump's condition as he wrestles with the virus that has killed more than 200,000 Americans.

"While not yet out of the woods, the team remains cautiously optimistic," Conley said in a memo late Saturday.

After Trump's physician and other doctors provided an update on Trump's health at a news conference Saturday, an administration official later identified by the Associated Press and the New York Times as chief of staff Mark Meadows met withreporters and described the president's condition earlier in the week as "very concerning."

Meadows said "the next 48 hours will be critical in terms of his care."

More: Anatomy of a White House response: Timeline of what officials said about Trump's COVID-19 battle

The differing messages drew criticism.

"During a crisis, public information must be complete, consistent, and accurate," said Jack Pitney,professor of government at Claremont McKenna College in California. "The White House has failed on all three counts. Recklessness, worsened by incompetence."

At one point Saturday, Conley said that Trump's case was"72 hours" old, meaning he would have been sick on Wednesday, the day he hosted a fundraiserin New Jersey.Conley later amended that comment, saying Trump who was tested daily did not have a positive result until Thursday night. The president took that testafter her learned that top aide Hope Hicks had been infected.

Conley issued a memo hours later on Saturday clarifying he should have said "third day," that is Thursday night, Friday and into Saturday, rather than "72 hours."

Matthew G. Heinz, a hospital physician andinternist from Tucson, Ariz.,noted thatConley side-stepped questions "about any lung involvement revealed in CT scans or chest films" involving Trump.

Heinz said it's unusual to use Remdesivir and dexamethasone therapy in mild casesand that could mean the doctors see evidence of viral pneumonia in the president's scans.

"The American people deserve complete transparency about the health of our leader which are still being denied by Dr. Conley and his team," Heinz said. "Its beyond galling for him to express regret for withholding information yesterday and then to walk away from the microphone after refusing to provide a clear response about findings chest X-rays and CT scans."

The president and his supporters expressed optimism over his prospects Sundayand predicted a quick return to the campaign trail, as new polls shows him losing ground to Democratic challenger Joe Biden.

Trump may be on the disabled list right now, "but very, very shortly hes going to be back in the game throwing 95-mile-an-hourfastballs," Steve Cortes, a Trump campaign adviser, saidon Fox News Sunday.

Trump spent part of his day on social media.In the mid-afternoon, Trump tweeted a thank you to supporters who gathered outside the hospital: "The fact is, they really love our Country and are seeing how we are MAKING IT GREATER THAN EVER BEFORE!"

Trump and aides have defended his decision to campaign and host large events in recent weeks, despite the pandemic.

Many people have gotten sick after those events, particularly a Sept. 26 event inthe White House Rose Gardenin which Trump announced his new Supreme Court nominee Amy Coney Barrett. Trump rarely wears masks; the same goes for many of his aides and supporters who attend his campaignrallies.

Seeking to reassure supporters, the White House use social media to convey the idea that Trump remains at work, even at Walter Reed Medical Center.

The White House sent out two pictures of Trump signing things Saturday one in which Trump is wearing a suit jacket and another in which he is not but the time stamps indicate the pictures were taken just ten minutes apart.

"Hes obviously not working, but MAGA will tell how hes working hard even when hes in the hospital," tweetedRobertKelly, professor of political science at Pusan University in South Korea. "Its all so predictable and insulting."

Trump also dictated a statement to his friend Rudy Giuliani, saying he felt fine and disputing negative news coverage of his condition.

I feel I could get out of here right now," Trump said, according to the statement Giuliani provided to The New York Post. "But theyre telling me there can always be a back-step with this disease. But I feel I could go out and do a rally."

More: Live updates on Trump and COVID-19: 'Feeling much better' in hospital video; Biden gets tested again today; brief acknowledgement on 'SNL'

More: President Trump has COVID-19: A timeline of his travels leading up to a positive coronavirus test

This all comes a time when Trump is seen asstruggling in his re-election race against Democrat Joe Biden.

Bidenhad a 51%-41% lead over Trump among adults who expect to vote, according toa Reuters/Ipsos poll released Sunday (and conducted Friday and Saturday). AnNBC News/Wall Street Journal poll also released Sunday gave Biden a lead of 14 percentage points. Thatsurvey was conducted after their contentious first debate, but before Trump went into the hospital.

During a four-minute video he tweeted out Saturday, Trump said he isis "starting to feel good"and is "doing well." and predicted he would return to the White House soon.

"I think I'll be back soon," Trump said. "And I look forward to finishing up the campaign, the way it was started."

Pitney, author of "Un-American: The Fake Patriotism of Donald J. Trump," said the upshot is no one can be sure how well the president is.

"Trump definitely has brief periods when he's well enough to sign blank pieces of paper or talk for a few minutes," Pitney said. "That's all we know for sure."

Conley said Sunday the bottom line is that the president is "doing really wellhe is responding."

He added: "If everything continues to go well, we'regoing to start discharge planning back to the White House."

Read or Share this story: https://www.usatoday.com/story/news/politics/2020/10/04/ups-and-downs-donald-trump-improving-covid-19-doctors-say/3615941001/

Follow this link:
'Ups and downs': Doctors say Donald Trump is improving while hospitalized; aides project image of calm - USA TODAY

It brings me no joy to say this butof course,the president has coronavirus.

Virtually every decision that Donald Trump has made since the severity of this crisis became undeniable has rendered this moment all but inevitable.

When you believe that the virus is just a bad flu and will disappear; when you believe that masks are not necessary; when you believe that the unvetted half-baked notions from mooches and sycophants carry more weight than science you may easily come to believe, and come to behave, as though your own choices do not matter.

Magical thinking may comfort you from reality but, in the end, cannot change it.

Magical thinking may occupy a news cycle, but it cannot impede the following one.

Magical thinking is not charming.

It is lazy.

Today is Day Zero. Let us reset.

If the presidents diagnosis and alarming clinical course over the past several days havenot silenced any remaining doubters about theseverity of COVID-19, we must simply brush their views aside as kooky and irrelevant and begin anew without their participation. We must develop an actual plan that will carry us through the fall and winter months and beyond if necessary.

Today is Day Zero.

Let us reset.

Let us commit to truly doing something to stop the spread of this horrific disease while vaccine trials are completed.

Starting today, the full resources of the United States government should --at long last --be mobilized to ensure that there are enough affordable tests, masks, treatment and eventually, vaccines, for every American. Our own leaders are responsible for the state of affairs. Therefore, all of this must be free or affordable foreveryone.

We have to modify our behaviors and do so in ways that do not further magnify the disproportionate suffering already visited upon Black, Latino and Native American people. We need to provide isolation for those who need it, especially those who live with at-risk persons.

After basic infrastructure and the health and medical sectors, we must prioritize schools as the single most essential business. Until case counts are low enough that all education can safely be conducted in-person, there should be no indoor restaurant dining and no medium-sized or large gatherings in communities with meaningful numbers of active cases. We need to produce scores of tents and heat lamps that will allow some activities that would normally take place indoors and move them outdoors. We need to invest in air filters and modernize our buildings for better circulation.

But before any of that, we need mask mandates for indoor activities and we need Congress to provide relief to Americans whose work cannot continue while we get things under control.

Meanwhile, we need to organize our research efforts. While the for-profit pharmaceutical industry has a role to play, experts at the National Institutes of Health must standardize research objectives and the desired outcomes of interest which has been done in the United Kingdom so that researchers with conflicts of interest do not game the system and mold their data to paint a rosy, but ultimately less useful, picture of their proposed therapeutics. We must spurn science by press release and we must demand transparency during the approval process, especially at the Food and Drug Administration, where politics has run amok.

Finally, we need to have confidence in our public health agencies and our leaders. Two steps would be helpful. First, the Centers for Disease Control and Prevention should be given the resources to collect and report all of the relevant information that the public and health officials need, without competing with other less prepared agencies, and without political interference. We need live data on case counts, hospitalization, mortality and more. We need demographic breakdowns for every iota of data so that we can monitor in as close to realtime as possible the effect that the virus is having in our most at-risk communities.

Second, the teams at the White House (and, at the moment, Walter Reed National Military Medical Center) must commit to transparency and integrity. The presidents team cannot be permitted to change its story from day-to-day for the purposes of optics. They must provide the American public with accurate information, or plainly state that they are not able to provide any information at all.

On Sunday, the president said he had learned a lot about coronavirus during his hospitalization. Obviously, he had notlearned nearly enoughfrom the deaths of over 200,000 Americans ...

We are now in our 10th month of this crisis. We have more than enough knowledge to guide our efforts to control this virus and do so in ways that will propel our economic recovery, not hinder it.

On Sunday, the president said he had learned a lot about coronavirus during his hospitalization. Obviously, he had notlearned nearly enoughfrom the deaths of over 200,000 Americans, including some of his own friends and colleagues.If only he had truly listened to the stories that my fellow physicians on the frontlines have been telling for months and months.

Regardless, Im glad he is catching up. But I remain unsure whether he and his supporters realize that letting the disease run its course the herd immunity strategy is a fundamentally flawed strategy that is doomed to fail. It costs lives and does nothing to reassure the public so that they can go about business as usual. For too long, many have been left to wonder whether our efforts to control this disease might somehow be worse than the virus itself. It is my hope that in his recovery, President Trump finally realizes that this disease truly is far, far worse than the cure.

Follow Cognoscenti on Facebook and Twitter.

View original post here:
Donald Trumps Magical Thinking About The Coronavirus - WBUR

President Donald Trump was taken Friday evening to Walter Reed National Military Medical Center, hours after testing positive for the coronavirus.

President Trump remains in good spirts, has mild symptoms, and has been working throughout the day, White House Press Secretary Kayleigh McEnany said in a statement. Out of an abundance of caution, and at the recommendation of his physician and medical experts, the President will be working from the presidential offices at Walter Reed for the next few days.

In a short video posted to his Twitter account shortly after 5:30 p.m., Trump said, "I think I'm doing very well, but we're going to make sure that things work out."

Late Friday night, McEnany released a statement from the president's physician that said the president was "doing very well," did not need supplemental oxygen and was starting remdesivir therapy.

"He has completed his first dose and is resting comfortably," Sean P. Conley, Trump's physician, wrote in the statement.

Earlier Friday afternoon, Conley had disclosed the president was receiving an experimental antibody treatment. Trump remains fatigued but in good spirits, Conley wrote in a memo at the time.

A tweet from the presidents account late Friday said things were going well:

Trump was hospitalized less than 24 hours after announcing that he and the first lady, Melania Trump, had tested positive for the virus. That revelation, late Thursday, came hours after news reports surfaced that one of the presidents closest aides, Hope Hicks, had become infected.

News of Trump's illness shook Washington and drew widespread expressions of concern from across the political spectrum on Friday.

"This cannot be a partisan moment," wrote Joe Biden, the Democratic nominee for president, on Twitter. "It must be an American moment. We have to come together as a nation."

Friday featured a steady flow of notifications from people close to Trump testing positive for COVID-19. Most had attended a ceremony last Saturday at the White House Rose Garden, where Trump officially nominated Judge Amy Coney Barrett as Supreme Court justice.

Footage of the event circulated widely on social media Friday showing guests talking, hugging and even fist bumping in close proximity without masks.

By Friday night, at least seven people who had attended the Rose Garden event announced they tested positive for COVID-19: the president and first lady, Sen. Thom Tillis of North Carolina, Sen. Mike Lee of Utah, University of Notre Dame President Rev. John Jenkins, former Trump adviser Kellyanne Conway and an unnamed journalist.

The White House Correspondents Association also said that two other journalists working at the White House, including Michael D. Shear of The New York Times, had tested positive. Neither journalist had attended the Rose Garden event.

The president's illness led to the postponement of a Trump campaign event in Texas that would have featured the president's son. Trumps campaign manager Bill Stepien has also tested positive for the virus, according to reports by Politico and The New York Times.

Donald Trump Jr. had been scheduled to appear in McAllen for a get-out-the-vote lunch event Friday, alongside Trump adviser Kimberly Guilfoyle. But local GOP officials said the event would be moved back to a later date "out of an abundance of caution."

"As many of you know, President Trump has tested for COVID19 and both Kimberly and Donald Trump Jr have been in close proximity to President Trump, our First Lady, Ivanka Trump, and Hope Hicks," the Hidalgo County GOP wrote on Facebook on Friday. "Kimberly Guilfoyle and Donald Trump Jr. will be in quarantine for the next couple of days until they test negative for COVID."

The party said the event will be rescheduled.

"The great news is, the event is not cancelled. It is postponed. We will see Donald Trump Jr. in Hidalgo County before Election Day," the party said.

Meanwhile, Gov. Greg Abbott said he was "lifting up prayers" for the president and first lady on Twitter at about 1 a.m. Friday, about an hour after the president announced the news.

"May Gods healing powers touch them, strengthen them, and raise them up," he said.

U.S. Sen. Ted Cruz, R-Texas, also said he was praying for the president and first lady. That sentiment was echoed by much of the Texas delegation in the U.S. House, with multiple members from both parties urging Texans to take the virus seriously.

"This virus should be taken very seriously - wishing them a full and speedy recovery," said U.S. Rep. Eddie Bernice Johnson, D-Dallas.

U.S. Rep. Louie Gohmert, R-Tyler, seemed to suggest on Twitter that Trump use the unproven drug hydroxychloroquine for treatment, even though in July the Food and Drug Administration revoked its emergency use authorization to treat COVID-19. The FDA found that the drug had no benefit for decreasing the likelihood of death or seeing recovery, but did provide a risk for heart rhythm problems. Gohmert tested positive for the virus in late July and has since recovered.

U.S. Rep. Joaquin Castro, D-San Antonio, also responded and asked that other members of Congress who were in close quarters with the president not show up for work Friday.

"Thats why we put in place proxy voting during this pandemic," Castro said. "Sincerely, A Co-worker."

Aliyya Swaby contributed to this story.

Go here to see the original:
Donald Trump hospitalized at Walter Reed after positive COVID-19 test - The Texas Tribune